A study published in JAMA Ophthalmology has identified a potential link between popular weight-loss medications and severe, ...

Summary: Researchers unmasked a slight, statistically measurable increase in the risk of developing a rare, potentially permanent blinding condition known as ischemic optic neuropathy (a sudden ...

A study at Rutgers University found the medications may be connected to a higher likelihood of ischemic optic neuropathy.

A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...

Use of GLP-1 RAs is associated with a higher risk for ischemic optic neuropathy compared with SGLT2is and DPP4is.

A new study found a small increase in the risk of a rare type of sudden vision loss among adults taking GLP-1 medications for ...

The prescription drugs have become household names thanks in part to their dramatic weight-loss effects and a number of celebrities, including Oprah Winfrey, Whoopi Goldberg and A ...

The Therapeutic Goods Administration has issued a safety warning for a rare, but serious risk of vision impairment from taking GLP-1-based drugs such as Ozempic and Wegovy.

The Toxic Avenger will open in theaters in 2025. This review is based on a screening of The Toxic Avenger at Fantastic Fest 2023. Troma Entertainment peaked during the rental-store reign of colorful, ...

In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase ...